2-[(E)-naphthalene-2-sulfonylimino]-imidazolidine-1-carbodithioic acid 3-thioxo-5,6-dihydro-imidazo[2,1-c][1,2,4]thiadiazol-7-yl ester

ID: ALA210620

PubChem CID: 44413038

Max Phase: Preclinical

Molecular Formula: C18H16N6O2S5

Molecular Weight: 508.70

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=S(=O)(NC1=NCCN1C(=S)SN1CCn2c1nsc2=S)c1ccc2ccccc2c1

Standard InChI:  InChI=1S/C18H16N6O2S5/c25-31(26,14-6-5-12-3-1-2-4-13(12)11-14)21-15-19-7-8-22(15)18(28)30-24-10-9-23-16(24)20-29-17(23)27/h1-6,11H,7-10H2,(H,19,21)

Standard InChI Key:  NOZMFXACNKQZDD-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 31 35  0  0  0  0  0  0  0  0999 V2000
    6.9477   -1.5511    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.7208   -1.8467    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    8.2426   -1.2078    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9900   -0.7290    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7911   -0.5126    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.8336    0.3132    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0605    0.6088    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5386   -0.0377    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.0684   -1.2465    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    5.7165    0.0086    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    5.3031    0.7226    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4795    0.7226    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.7165    1.4366    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    3.9881    1.3890    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2034    1.1363    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2034    0.3128    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.9881    0.0560    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2486   -0.7287    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.6604   -1.3132    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    4.2486   -1.8978    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.0755   -0.7287    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.0755   -1.8978    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2838   -1.6864    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7162   -3.2786    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2975   -2.6933    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9132   -3.0662    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7074   -2.2698    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9163   -2.0514    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3305   -2.6283    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5409   -3.4267    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3316   -3.6413    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 11 13  2  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 19 21  2  0
 19 22  1  0
 22 23  2  0
  1  2  1  0
 23 27  1  0
  2  3  1  0
  3  5  1  0
 26 24  1  0
  4  1  2  0
 24 25  2  0
 25 22  1  0
  4  5  1  0
  5  6  1  0
 26 27  1  0
  6  7  1  0
 27 28  2  0
  7  8  1  0
 28 29  1  0
  8  4  1  0
 29 30  2  0
  3  9  2  0
 30 31  1  0
 31 26  2  0
M  END

Associated Targets(Human)

KYSE-510 (286 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 508.70Molecular Weight (Monoisotopic): 507.9938AlogP: 3.23#Rotatable Bonds: 3
Polar Surface Area: 82.83Molecular Species: NEUTRALHBA: 10HBD: 1
#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 9.65CX Basic pKa: 1.40CX LogP: 4.75CX LogD: 4.75
Aromatic Rings: 3Heavy Atoms: 31QED Weighted: 0.43Np Likeness Score: -1.49

References

1. Saczewski J, Brzozowski Z, Saczewski F, Bednarski PJ, Liebeke M, Gdaniec M..  (2006)  Synthesis and in vitro anti-tumor activity of N-{1-[(3-thioxo-5,6-dihydroimidazo[2,1-c][1,2,4]thiadiazol-7-ylthio)thiocarbonyl]-2-imidazolidene}arylsulfonamides.,  16  (14): [PMID:16682194] [10.1016/j.bmcl.2006.04.067]

Source